E-LIB Suche - Ergebnisse für: Herranz, Urbano Anido

1

Outcomes and patterns of use of Radium-223 in metastatic ca..:

Anido-Herranz, Urbano ; Fernandez-Calvo, Ovidio ; Ruiz-Bañobre, Juan...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

A three-gene expression score for predicting clinical benef..:

Betancor, Yoel Z. ; Ferreiro-Pantín, Miriam ; Anido-Herranz, Urbano...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

DataSheet_1_A three-gene expression score for predicting cl..:

Yoel Z. Betancor ; Miriam Ferreiro-Pantín ; Urbano Anido-Herranz...
doi:10.3389/fimmu.2024.1374728.s001. , 2024

Link: https://doi.org/10.3389/..

4

DataSheet_1_Outcomes and patterns of use of Radium-223 in m..:

Urbano Anido-Herranz ; Ovidio Fernandez-Calvo ; Juan Ruiz-Bañobre...
doi:10.3389/fonc.2024.1385466.s001. , 2024

Link: https://doi.org/10.3389/..

5

Clinical outcomes of immunotherapy-based first-line regimen..:

Anido Herranz, U. ; Fernandez-Diaz, N. ; Garcia-Gonzalez, J....
European Urology Open Science. 57 (2023) - p. S233 , 2023

Link: https://doi.org/10.1016/..

6

Phase II Trial Evaluating Olaparib Maintenance in Patients ..:

Juan Fita, María José ; Anido Herranz, Urbano ; Mendez-Vidal, María José...
Cancers. 15 (2023) 21 - p. 5223 , 2023

Link: https://doi.org/10.3390/..

7

Clinical, molecular, and immune correlates of the Immunothe..:

Ferreiro-Pantín, M. ; Anido-Herranz, U. ; Betancor, Y.Z....
ESMO Open. 8 (2023) 4 - p. 101611 , 2023

Link: https://doi.org/10.1016/..

8

Publisher Correction: Clinical efficacy and biomarker analy..:

Powles, Thomas ; Kockx, Mark ; Rodriguez-Vida, Alejo...
Nature Medicine. 29 (2023) 12 - p. 3271-3271 , 2023

Link: https://doi.org/10.1038/..

9

Impact of concurrent tumour events on the prostate cancer o..:

Lozano, Rebeca ; Castro, Elena ; Lopez-Campos, Fernando...
European Journal of Cancer. 185 (2023) - p. 105-118 , 2023

Link: https://doi.org/10.1016/..

10

Phase II Trial Evaluating Olaparib Maintenance in Patients ..:

María José Juan Fita ; Urbano Anido Herranz ; María José Mendez-Vidal...
https://www.mdpi.com/2072-6694/15/21/5223. , 2023

Link: https://doi.org/10.3390/..

11

Phase II Trial Evaluating Olaparib Maintenance in Patients ..:

Juan Fita, María José ; Anido Herranz, Urbano ; Mendez-Vidal, María José...
The following supporting information can be downloaded at: https:// www.mdpi.com/article/10.3390/cancers15215223/s1, Table S1. Exclusion criteria; Table S2. Individual patient data for efficacy outcomes; Table S3. Individual patient data for key safety outcomes.. , 2023

Link: https://hdl.handle.net/2..

12

Use of multikinase inhibitors/lenvatinib concomitant with r..:

Herranz, Urbano Anido
Cancer Medicine. 11 (2022) S1 - p. 47-53 , 2022

Link: https://doi.org/10.1002/..

13

Final Results of Neoadjuvant Atezolizumab in Cisplatin-inel..:

Szabados, Bernadett ; Kockx, Mark ; Assaf, Zoe June...
European Urology. 82 (2022) 2 - p. 212-222 , 2022

Link: https://doi.org/10.1016/..

14

Exploring the synergistic effects of cabozantinib and a pro..:

Durán, Ignacio ; Castellano, Daniel ; Puente, Javier...
Oncotarget. 13 (2022) 1 - p. 237-256 , 2022

Link: https://doi.org/10.18632..

15

Final results of neoadjuvant atezolizumab in cisplatin-inel..:

Szabados, Bernadett ; Kockx, Mark ; Assaf, Zoe June...
https://eprints.soton.ac.uk/467740/1/EurUrol_ABACUS_clean.docx. , 2022

Link: https://eprints.soton.ac..